US 10407678
Compositions for modulating expression of C9ORF72 antisense transcript
granted A61PA61P21/00A61P25/16
Quick answer
US patent 10407678 (Compositions for modulating expression of C9ORF72 antisense transcript) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61P, A61P21/00, A61P25/16, A61P25/28